Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen Nabs CE Mark for High-Throughput SARS-CoV-2 Test Kit

NEW YORK – Qiagen said on Tuesday that it has received a CE-IVD mark for its Artus SARS-CoV-2 Prep&Amp UM Kit for high-throughput PCR-based COVID-19 testing.

The kit is now commercially available in the EU and other markets accepting the CE-IVD mark, and Qiagen has submitted an Emergency Use Authorization application for the assay to the US Food and Drug Administration.

The kit uses the same technology as the research-use-only QIAprep&amp viral RNA UM Kit that the company launched in October, and features a liquid-based sample preparation step that the company said takes no more than two minutes with the provided real-time PCR assay. It uses common transport media, such as universal transport media, as the starting material and includes all testing reagents, yielding results more quickly than standard extraction-based real-time PCR workflows and supporting up to 672 samples per cycler in an eight-hour shift, Qiagen said.

Total time to result is less than an hour, and the kit is compatible with the Qiagen RGQ MDx and Thermo Fisher Scientific ABI 7500 Dx real-time PCR systems.

"We continue to see the need for a large volume of PCR tests as COVID-19 cases continue around the world — and our novel technology will enable clinical labs to drastically increase testing capacity with existing infrastructure," Jean-Pascal Viola, senior VP and head of molecular diagnostics and corporate business development at Qiagen, said in a statement. "It is also an exciting and versatile technology with additional potential applications."

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.